Atypical hyperplasia and lobular carcinoma in situ are rare proliferative breast lesions,
growing inside ducts and terminal ducto-lobular units. They represent a marker of increased …

Atypical lobular hyperplasia and lobular carcinoma in situ are lesions that occur relatively
infrequently in the breast. They are also referred to under the umbrella term of 'lobular …

The term lobular neoplasia refers to a spectrum of lesions featuring atypical lobular
hyperplasia and lobular carcinoma in situ (LCIS). The histopathological characteristics of …

Lobular carcinoma in situ and atypical lobular hyperplasia were first described over 50 years
ago. Despite this long incubation period, the biological nature of the lesions remains …

Lobular neoplasia broadly defines the spectrum of changes within the lobule, ranging from
atypical lobular hyperplasia (ALH) to lobular carcinoma in situ (LCIS). This continuum of …

Lobular neoplasia is increasingly being detected, probably due to the widespread screening
for breast malignancies. The understanding of lobular neoplasia is undergoing a paradigm …

Purpose: Classical type of lobular neoplasia (LN) encompassing both atypical lobular
hyperplasia and classical lobular carcinoma in situ of the breast is a lesion with uncertain …

Context.—The upgrade rate to carcinoma on excision for atypical lobular hyperplasia
diagnosed on breast biopsy is controversial. Objective.—To review cases with isolated …

Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are nonmalignant breast
lesions that confer a 4-to 10-fold increased risk for breast cancer in women. Often, AH and …

OBJECTIVES: To determine the incidence of malignancy (invasive carcinoma or DCIS) in
patients diagnosed with lobular neoplasia (B3) on core needle biopsy (CNB) of breast …